Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BIOTIS (TM) STARCH HYDROLYSIS WITH BCP

K-Number: K874174 · 1987-12-04

ApplicantOtisville Biopharm, Inc.
Decision Date1987-12-04
Product CodeJSF
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BIOTIS (TM) STARCH HYDROLYSIS WITH BCP is the device name listed in this FDA 510(k) record. The listed applicant is Otisville Biopharm, Inc.. It received FDA 510(k) clearance on 1987-12-04 under 510(k) number K874174. The device is classified under product code JSF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BIOTIS (TM) STARCH HYDROLYSIS WITH BCP?

BIOTIS (TM) STARCH HYDROLYSIS WITH BCP is a medical device that received FDA 510(k) clearance on 1987-12-04. The listed applicant is Otisville Biopharm, Inc.. The 510(k) number is K874174.

When did BIOTIS (TM) STARCH HYDROLYSIS WITH BCP receive FDA 510(k) clearance?

BIOTIS (TM) STARCH HYDROLYSIS WITH BCP received FDA 510(k) clearance on 1987-12-04, under 510(k) number K874174.

Who is the listed applicant for BIOTIS (TM) STARCH HYDROLYSIS WITH BCP?

The FDA 510(k) record lists Otisville Biopharm, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BIOTIS (TM) STARCH HYDROLYSIS WITH BCP?

The FDA product code for BIOTIS (TM) STARCH HYDROLYSIS WITH BCP is JSF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Otisville Biopharm, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K874176BIOTIS (TM) HAEMOPHILUS DUCREYIK874179BIOTIS (TM) SABHI (DOUBLE POUR)K874175BIOTIS (TM) MUELLER HINTON W/4% SALT, 6MCG/ML OXACK874178BIOTIS (TM) BCYE SELECTIVEK874177BIOTIS (TM) BCYEK874173BIOTIS (TM) BHI WITH HRBC, CHLORA/GENTAM/CYCLOHEXI

View all 8 devices →

Related Devices (Code: JSF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K880946NUTRIENT GELATIN - PRODUCT NUMBER T2860Lakewood Biochemical Co., Inc.K880126LAURYL TRYPTOSE BROTHHardy MediaK880119MOELLERS DECARBOXYLASE, ONITHINEHardy MediaK880120MOELLERS DECARBOXYLASE, LYSINEHardy MediaK880139ONPG TEST REAGENTHardy MediaK880113CYSTINE TRYPTIC MEDIUM W/LACTOSEHardy Media

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑